Neuromuscular Specialist

Education

Search

Saved Activities

0 Activities

0 Activities

Filter Content

Page 1 of 2

Results 1 - 75 of 76

Addressing DMD Time to Diagnosis: Microlearning for Pediatricians & Primary Care

Improving the Management of Patients with DMD: Emerging Evidence & Treatment Strategies

9299 mda enduring

Evolutions in the Management of DMD: Treatment Implications for the Present and Future

9256-0002_Thumbnail

Conference Updates in DMD and LGMD (WMS and MDA)

Fall 2023 Neuromuscular Conference Updates

9270-lgmd explore

Limb-Girdle Muscular Dystrophy EXPLORE Module

Rett Syndrome: Delayed Diagnosis, Patient Perspectives & Evolving Treatment - Rapid Recap

Rett Syndrome: Delayed Diagnosis, Patient Perspectives & Evolving Treatment - Slide Deck

Rett Syndrome: Delayed Diagnosis, Patient Perspectives & Evolving Treatment

Practical Considerations for DMD Management in the Era of Gene Therapy

animation-263x149

Considerations to Encourage Patient Engagement and Shared Decision-making

9235-0005_thumb

Recent Developments in Immune Therapies for Multiple Sclerosis

9256-0001-Thumb

Spring Neuromuscular Conference Updates

9235-mod4-263x149

The Connection Between Viruses and Other Factors Contributing to the Development of MS

01.DMD-VirtueMart5

DMD Micro-Learning Library

9170-0011_263x149

DMD Conference Coverage: ICNMD and WMS

9156-LSD-264x150

Understanding Lysosomal Storage Disorders: From Newborn Screening to Treatments

9162-0001-DMD_264x150

Gene Therapy and the Future of DMD Treatment: An EXPLORE Learning Experieince

9152-sma-explore

Updates in Spinal Muscular Atrophy: An EXPLORE Learning Experience

Growing Importance of Newborn Screening in DMD

The Immune Response in DMD Gene Therapies

New Data from Gene Therapy Clinical Trials in DMD

Changing the Phenotype of DMD

DMD and Gene Therapy: What's on the Horizon?

Updates in Duchenne Muscular Dystrophy: A Focus on Emerging Gene Therapy

LGMD: Mutation-specific Nomenclature

LGMD Symptomatology

LGMD Mutations and Disease Types

Tests and Outcomes - DMD

Genes, Exons, and the Pathophysiology of DMD

The Natural History of DMD

Updates in SMA: Cure SMA Conference Coverage (CME/CE)

New and Emerging Options for the Management of MS

Comorbidities and Selection of DMTs

Conference Coverage on DMD and LGMD: Latest Developments

Management of Breakthrough Disease Activity

Minimizing Neurodegenerative Damage in Patients with MS

Recognizing Progressive Disease: A Challenge in the MS Clinic

MDA Conference Coverage

Engaging Patients with Shared Decision-Making Strategies and the Comprehensive Care Team

Advances in MS Assessment: Biomarkers and Imaging

Defining the Clinical Course of Multiple Sclerosis

Engaging the Patient in Treatment Choices

DMT Treatment Review

WMS Conference Coverage on DMD and LGMD: Experts Reporting From the Field

Updates in SMA: WMS Conference Coverage (CME/CE)

Updates in SMA: WMS Conference Coverage

SMA: Introduction and Key Concepts

Conference Coverage on DMD & LGMD

Understanding Lysosomal Storage Disorders

Advances in Multiple Sclerosis (AIMS) Primer: 3rd Edition

A Practical Guide to Rehabilitation in Multiple Sclerosis: 2nd Edition

SMA Updates from Around the World

9920-0004-conf_covg_icon_263x149

Updates in SMA from Charlotte, North Carolina

Updates in SMA from Austin, Texas

Technology Improving SMA Patients’ Quality of Life

Nusinersen Treatment Outcomes in Later-Onset SMA

Patients with Severe SMA Need Additional Respiratory Management

Clear Expectations Needed in SMA Patient Management

Improvements in Quality of Life for Patients with Neuromuscular Diseases

Updates in SMA and Gene Therapy from Copenhagen, Denmark

The Changing Landscape of SMA–Updates from Copenhagen, Denmark

Are You Ready for Gene Replacement Therapy?

The Changing Landscape of SMA–Updates from Anaheim, CA

sma-journal-icon_263x0

Gene Therapy for SMA: An Emerging Treatment Option for a Devastating Disease

SMA: Data, Insights and Practice

From Bench to Bedside: Gene Therapy Approaches for Rare Diseases

What’s New in Spinal Muscular Atrophy? Reporting from Dallas

SMA Updates from Los Angeles

Updates in SMA and Gene Therapy from Arlington, VA

Targeting B-cells in Primary Progressive MS (PPMS)

Comorbidities and Selection of DMTs

The Gut Microbiota in MS

Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS

Individualizing Patient Education in Treatment Choice: Practical Strategies

Page 1 of 2